Rimcazole (BW 234U), a novel antipsychotic agent whose mechanism of action cannot be explained by a direct blockade of postsynaptic dopaminergic receptors in brain
- 1 November 1986
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 9 (3) , 171-188
- https://doi.org/10.1002/ddr.430090302
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- Species differences in monoamine oxidase-A and -B as revealed by sensitivity to trypsinLife Sciences, 1984
- Dopaminergic D-3 binding sites are not presynaptic autoreceptorsNature, 1983
- Inhibition of adenosine uptake into rat brain synaptosomes by prostaglandins, benzodiazepines and other centrally active compoundsGeneral Pharmacology: The Vascular System, 1983
- A rapid method for the regional dissection of the rat brainPharmacology Biochemistry and Behavior, 1980
- Benzodiazepine receptors in rat brainNature, 1977
- Inhibition of histidine decarboxylase. Derivatives of histidineJournal of Medicinal Chemistry, 1977
- Alpha-noradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist statesLife Sciences, 1976
- Utilization of sodium-dependent high affinity choline uptake as a measure of the activity of cholinergic neuronsLife Sciences, 1975
- Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topographyNature, 1974